Centene Corp (CNC)

Industry Healthcare Plans


This stock can be held in an Investment ISA and an Investment Account
Sell

$57.00

Buy

$59.43

arrow-down$-0.72 (-1.23%)

Prices updated at 04 Mar 2025, 22:11 EST
| Prices minimum 15 mins delay
|
Prices in USD

Centene Corp offers healthcare plans to United States government sponsored healthcare programs. The company primarily focuses on uninsured individuals and helps them access care facilities, and social services through government subsidized programs.

Income statement

20232024
153,999m163,071m
17,315m16,829m
3,459m3,188m
2.251.96
2,702m3,305m
5,616m6,200m
Sales, General and administrative12,563m12,400m
Interest expenses725m702m
Provision for income taxes899m963m
Operating expenses13,856m13,641m
Income before taxes3,598m4,257m
Net income available to common shareholders2,702m3,305m
4.976.33
Net interest income-725m-702m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)4.956.31
Free cash flow per share9.85650.46
Book value/share47.32655.0648
Debt equity ratio0.7194270.725521

Balance sheet

20232024
Current assets40,756m37,999m
Current liabilities36,716m34,261m
Total capital43,550m44,833m
Total debt18,877m19,429m
Total equity25,840m26,410m
Total non current liabilities--
Loans17,710m18,423m
Total assets84,641m82,445m
Total liabilities--
Cash and cash equivalents17,193m14,063m
Common stock534m496m

Cash flow

20232024
Cash at beginning of period12,330m17,452m
Cash dividends paid--
7,254m-490m
Investments (gains) losses-1,191m-1,052m
17,452m14,156m
Net income--
8,053m154m
-799m-644m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.